Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Benito

Showing results (121-130 of 154) with videos related to

Pageof 16
Sort By:
European Radiology|July 26, 2022
Non-hypervascular hepatobiliary phase hypointense lesions detected in patients with hepatocellular carcinoma: a post hoc analysis of SORAMIC trial to identify risk factors for progressionOsman Öcal, Christoph J Zech, Matthias P Fabritius, et al.
Nutrients|May 6, 2020
Association of the <i>SH2B1</i> rs7359397 Gene Polymorphism with Steatosis Severity in Subjects with Obesity and Non-Alcoholic Fatty Liver DiseaseNuria Perez-Diaz-Del-Campo, Itziar Abete, Irene Cantero, et al.
Panminerva Medica|April 19, 2022
A nutrigenetic tool for precision dietary management of non-alcoholic fatty liver disease deeming insulin resistance markersNuria Perez-Diaz-Del-Campo, Jose I Riezu-Boj, Bertha A Marin-Alejandre, et al.
Nutrients|October 27, 2019
The Metabolic and Hepatic Impact of Two Personalized Dietary Strategies in Subjects with Obesity and Nonalcoholic Fatty Liver Disease: The Fatty Liver in Obesity (FLiO) Randomized Controlled TrialBertha Araceli Marin-Alejandre, Itziar Abete, Irene Cantero, et al.
European Journal of Nutrition|January 21, 2021
Differential response to a 6-month energy-restricted treatment depending on SH2B1 rs7359397 variant in NAFLD subjects: Fatty Liver in Obesity (FLiO) StudyNuria Perez-Diaz-Del-Campo, Bertha Araceli Marin-Alejandre, Irene Cantero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2004
Intratumoral injection of dendritic cells engineered to secrete interleukin-12 by recombinant adenovirus in patients with metastatic gastrointestinal carcinomasGuillermo Mazzolini, Carlos Alfaro, Bruno Sangro, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 3, 2014
Pilot randomized trial of selective internal radiation therapy vs. chemoembolization in unresectable hepatocellular carcinomaFrank T Kolligs, Jose I Bilbao, Tobias Jakobs, et al.
European Radiology|September 1, 2021
Correlation of liver enhancement in gadoxetic acid-enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trialOsman Öcal, Bora Peynircioglu, Christian Loewe, et al.
European Journal of Nutrition|August 29, 2020
Dietary intake of specific amino acids and liver status in subjects with nonalcoholic fatty liver disease: fatty liver in obesity (FLiO) studyCristina Galarregui, Irene Cantero, Bertha Araceli Marin-Alejandre, et al.
Frontiers in Immunology|November 15, 2023
Novel mediator in anaphylaxis: decreased levels of miR-375-3p in serum and within extracellular vesicles of patientsEmilio Nuñez-Borque, Sergio Fernandez-Bravo, Pablo Rodríguez Del Rio, et al.
Pageof 16

Showing results (121-130 of 154) with videos related to

Sort By:
Pageof 16
European Radiology|July 26, 2022
Non-hypervascular hepatobiliary phase hypointense lesions detected in patients with hepatocellular carcinoma: a post hoc analysis of SORAMIC trial to identify risk factors for progressionOsman Öcal, Christoph J Zech, Matthias P Fabritius, et al.
Nutrients|May 6, 2020
Association of the <i>SH2B1</i> rs7359397 Gene Polymorphism with Steatosis Severity in Subjects with Obesity and Non-Alcoholic Fatty Liver DiseaseNuria Perez-Diaz-Del-Campo, Itziar Abete, Irene Cantero, et al.
Panminerva Medica|April 19, 2022
A nutrigenetic tool for precision dietary management of non-alcoholic fatty liver disease deeming insulin resistance markersNuria Perez-Diaz-Del-Campo, Jose I Riezu-Boj, Bertha A Marin-Alejandre, et al.
Nutrients|October 27, 2019
The Metabolic and Hepatic Impact of Two Personalized Dietary Strategies in Subjects with Obesity and Nonalcoholic Fatty Liver Disease: The Fatty Liver in Obesity (FLiO) Randomized Controlled TrialBertha Araceli Marin-Alejandre, Itziar Abete, Irene Cantero, et al.
European Journal of Nutrition|January 21, 2021
Differential response to a 6-month energy-restricted treatment depending on SH2B1 rs7359397 variant in NAFLD subjects: Fatty Liver in Obesity (FLiO) StudyNuria Perez-Diaz-Del-Campo, Bertha Araceli Marin-Alejandre, Irene Cantero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2004
Intratumoral injection of dendritic cells engineered to secrete interleukin-12 by recombinant adenovirus in patients with metastatic gastrointestinal carcinomasGuillermo Mazzolini, Carlos Alfaro, Bruno Sangro, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 3, 2014
Pilot randomized trial of selective internal radiation therapy vs. chemoembolization in unresectable hepatocellular carcinomaFrank T Kolligs, Jose I Bilbao, Tobias Jakobs, et al.
European Radiology|September 1, 2021
Correlation of liver enhancement in gadoxetic acid-enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trialOsman Öcal, Bora Peynircioglu, Christian Loewe, et al.
European Journal of Nutrition|August 29, 2020
Dietary intake of specific amino acids and liver status in subjects with nonalcoholic fatty liver disease: fatty liver in obesity (FLiO) studyCristina Galarregui, Irene Cantero, Bertha Araceli Marin-Alejandre, et al.
Frontiers in Immunology|November 15, 2023
Novel mediator in anaphylaxis: decreased levels of miR-375-3p in serum and within extracellular vesicles of patientsEmilio Nuñez-Borque, Sergio Fernandez-Bravo, Pablo Rodríguez Del Rio, et al.
Pageof 16